Your weekly roundup of the latest news from Drug Topics®.
Childhood vaccinations took a downturn during the pandemic. Now is the time to get them done and pharmacists can help.
Moderna has announced positive topline results from a phase 3 pivotal efficacy study of mRNA-1345, the company’s investigational mRNA vaccine targeting respiratory syncytial virus (RSV) in older adults.
The updates include new recommendations for COVID-19 and pneumococcal vaccines.
Previously hepatitis B vaccines have offered lower levels of protection for people living with HIV. New research indicates that a 3-dose series could offer much better protection.
New approvals include gene therapies, first-in-class drugs, treatments for rare diseases, and cancer, as well as biosimilars.